Serum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To evaluate preoperative anti-Müllerian hormone (AMH) levels in women with endometrioma or other benign ovarian cysts and differences of AMH changes according to various characteristics. Methods: Ninety-seven patients aged 20 to 39 years who underwent surgery for benign ovarian cyst were enrolled retrospectively. Of these, 65 patients were diagnosed as endometriomas, and 32 had other benign cysts. Serum AMH, mean, maximum, and total diameter of ovarian cysts were measured. The AMH levels were compared according to pathology (endometrioma vs. other benign cyst), size of ovarian cyst, age-matched AMH quartile percentile and characteristics of endometrioma.Results: Preoperative serum AMH level was significantly lower in endometrioma group than other benign cyst group (4.12 ± 2.42 ng/mL vs. 6.02 ± 2.29 ng/mL, P < 0.001). Serum AMH level was significantly lower in endometrioma group, especially in patients aged 30 to 39 years. Dividing to age-matched AMH quartile percentile, there were significantly fewer patients with AMH level ≥ 75 percentile in endometrioma group (24.6% vs. 50.0%, P = 0.035). Among 4 subgroups of endometrioma, patients with AMH level ≥ 75 percentile were significantly decreased in multiple bilateral endometrioma group. Mean and total diameter of cysts were negatively correlated with preoperative serum AMH level in other benign cyst group.Conclusion: We suggest that preoperative AMH level measurement might be considered in women with endometrioma, especially in 30 to 39 years old, multiple bilateral type, or big-sized other benign ovarian cyst to assess the diminished ovarian reserve. (J Menopausal Med 2015;21:142-148)
Abstract
Objectives: To evaluate preoperative anti-Müllerian hormone (AMH) levels in women with endometrioma or other benign ovarian cysts and differences of AMH changes according to various characteristics. Methods: Ninety-seven patients aged 20 to 39 years who underwent surgery for benign ovarian cyst were enrolled retrospectively. Of these, 65 patients were diagnosed as endometriomas, and 32 had other benign cysts. Serum AMH, mean, maximum, and total diameter of ovarian cysts were measured. The AMH levels were compared according to pathology (endometrioma vs. other benign cyst), size of ovarian cyst, age-matched AMH quartile percentile and characteristics of endometrioma.Results: Preoperative serum AMH level was significantly lower in endometrioma group than other benign cyst group (4.12 ± 2.42 ng/mL vs. 6.02 ± 2.29 ng/mL, P < 0.001). Serum AMH level was significantly lower in endometrioma group, especially in patients aged 30 to 39 years. Dividing to age-matched AMH quartile percentile, there were significantly fewer patients with AMH level ≥ 75 percentile in endometrioma group (24.6% vs. 50.0%, P = 0.035). Among 4 subgroups of endometrioma, patients with AMH level ≥ 75 percentile were significantly decreased in multiple bilateral endometrioma group. Mean and total diameter of cysts were negatively correlated with preoperative serum AMH level in other benign cyst group.Conclusion: We suggest that preoperative AMH level measurement might be considered in women with endometrioma, especially in 30 to 39 years old, multiple bilateral type, or big-sized other benign ovarian cyst to assess the diminished ovarian reserve. (J Menopausal Med 2015;21:142-148)
참고문헌 (33)
- 김창래, "난소종양으로 수술한 환자의 임상 조직학적 양상 및 수 술 전 CA 125의 의미", 대한폐경학회지, 19(1), pp.26~35 (2013), 대한폐경학회
- 박정우, "Discrimination between Benign and Malignant Pelvic Masses Using the Risk of Malignancy Index 1", 대한폐경학회지, 19(1), pp.18~25 (2013), 대한폐경학회
- ACOG Committee on Practice Bulletins., "ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999(replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists", Int J Gynaecol Obstet, 71, pp.183~196 (2000)
- 문명진, "에스트로겐 수용체 유전자의 다형성과 자궁내막증", 대한폐경학회지, 19(2), pp.64~73 (2013), 대한폐경학회
- D'Hooghe TM., "Endometriosis and subfertility : is the relationship resolved?", Semin Reprod Med, 21, pp.243~254 (2003)
- Benaglia L., "Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation", Hum Reprod, 24, pp.2183~2186 (2009)
- The American Fertility Society., "Classification of endometriosis", Fertil Steril, 32, pp.633~634 (1979)
- Gleicher N., "Defining ovarian reserve to better understand ovarian aging", Reprod Biol Endocrinol, 9, pp.23~ (2011)
- Sills ES., "Ovarian reserve screening in infertility : practical applications and theoretical directions for research", Eur J Obstet Gynecol Reprod Biol, 146, pp.30~36 (2009)
- Al-Azemi M., "Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction", Hum Reprod, 26, pp.414~422 (2011)
- Sun Young Shin, "Analysis of Serum Levels of Anti-Mullerian Hormone, Inhibin B, Insulin- Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Follicle-Stimulating Hormone with Respect to Age and Menopausal Status and Follicle-Stimulating Hormone with Respect to Age and Menopausal Status", Journal of Korean Medical Science, 23(1), pp.104~110 (2008), 대한의학회
- La Marca A., "Anti-Mullerian hormone(AMH)as a predictive marker in assisted reproductive technology(ART)", Hum Reprod Update, 16, pp.113~130 (2010)
- Cate RL., "Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells", Cell, 45, pp.685~698 (1986)
- Toner JP., "Why we may abandon basal folliclestimulating hormone testing : a sea change in determining ovarian reserve using antimullerian hormone", Fertil Steril, 99, pp.1825~1830 (2013)
- Shebl O., "Anti muellerian hormone serum levels in women with endometriosis : a case-control study", Gynecol Endocrinol, 25, pp.713~716 (2009)
- Campos CS., "Follicular-fluid anti-Müllerian hormone concentration is similar in patients with endometriosis compared with non-endometriotic patients", Reprod Biomed Online, 21, pp.470~473 (2010)
- Pacchiarotti A., "Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis", Eur J Obstet Gynecol Reprod Biol, 172, pp.62~64 (2014)
- Ji Hee Yoo, "Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation", Clinical and Experimental Reproductive Medicine, 38(2), pp.93~97 (2011), 대한생식의학회
- Kitajima M., "Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis", Fertil Steril, 96, pp.685~691 (2011)
- Zhang X., "Redoxinduced apoptosis of human oocytes in resting follicles in vitro", J Soc Gynecol Investig, 13, pp.451~458 (2006)
- Halis G., "Endometriosis and inflammation in infertility", Ann N Y Acad Sci, 1034, pp.300~315 (2004)
- Stilley JA., "Cellular and molecular basis for endometriosis-associated infertility", Cell Tissue Res, 349, pp.849~862 (2012)
- Gupta S., "Pathogenic mechanisms in endometriosisassociated infertility", Fertil Steril, 90, pp.247~257 (2008)
- de Vet A., "Antimullerian hormone serum levels : a putative marker for ovarian aging", Fertil Steril, 77, pp.357~362 (2002)
- Lee MM., "Mullerian inhibiting substance in humans : normal levels from infancy to adulthood", J Clin Endocrinol Metab, 81, pp.571~576 (1996)
- Kaya C., "Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction", Fertil Steril, 94, pp.2202~2207 (2010)
- La Marca A., "Anti-Mullerian hormone(AMH) : what do we still need to know?", Hum Reprod, 24, pp.2264~2275 (2009)
- Chang HJ., "Impact of laparoscopic cystectomy on ovarian reserve : serial changes of serum anti-Müllerian hormone levels", Fertil Steril, 94, pp.343~349 (2010)
- Streuli I., "In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery", Hum Reprod, 27, pp.3294~3303 (2012)
- Somigliana E., "Surgical measures for endometriosis-related infertility: a plea for research", Placenta, 32(Suppl 3), pp.S238~S242 (2011)
- de Carvalho BR., "Anti-müllerian hormone is the best predictor of poor response in ICSI cycles of patients with endometriosis", Clin Exp Obstet Gynecol, 38, pp.119~122 (2011)
- Falconer H., "IVF outcome in women with endometriosis in relation to tumour necrosis factor and Anti-Müllerian hormone", Reprod Biomed Online, 18, pp.582~588 (2009)
- Papaleo E., "Deep pelvic endometriosis negatively affects ovarian reserve and the number of oocytes retrieved for in vitro fertilization", Acta Obstet Gynecol Scand, 90, pp.878~884 (2011)